The Centers for Medicare and Medicaid Services is retiring its Medicare national coverage determination restricting coverage of amyloid PET scans for Alzheimer’s and dementia patients to use in clinical trials, and will allow its Medicare Administrative Contractors to establish coverage policy on a regional basis going forward, according to a final decision released by the agency on 13 October.
Key Takeaways
-
Medicare is lifting the restrictions on coverage of amyloid PET scans, but declined to establish a new policy mandating broad coverage.
The decision also removes the one scan per patient per lifetime requirement in the NCD. The action confirms the proposed...
